New imaging test for adrenal gland hormone disorder
Part of Hormones & metabolism clinical trials.
This trial tests a special PET scan that may help doctors find the exact cause of high blood pressure related to an adrenal gland problem. It could help decide if surgery or medicine is the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an adrenal mass seen on a CT scan or have been diagnosed with primary aldosteronism (a condition where the adrenal gland makes too much of a hormone called aldosterone).
- You are willing and able to follow the study procedures and sign a consent form.
- If you can become pregnant, you must be surgically sterile, past menopause for over a year, or use reliable birth control.
- If you are a man, you must use reliable birth control during the study and not donate sperm.
- You do not have severe health problems like serious heart, kidney, liver, or brain disease, and you do not have claustrophobia.
- You have not used experimental drugs or devices in the past month, and you do not have a history of drug or alcohol abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes and molecules in people with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone), primary hypertension (high blood pressure), and healthy volunteers. The goal is to better understand these conditions and find better ways to diagnose and treat them.
This trial tests a new type of PET scan that may help find which adrenal gland is causing your condition, compared to the usual care. If successful, it could help guide surgery decisions.
This trial tests a special PET scan (68Ga-Pentixafor) to see if it can replace a more invasive blood test (AVS) for finding which adrenal gland is causing high blood pressure and high cortisol levels. It may help patients avoid a complicated procedure.
This study tests whether a new PET imaging tracer can help doctors better identify which adrenal gland is causing high aldosterone levels. It aims to improve diagnosis and guide treatment for people with primary aldosteronism.
This trial tests a new imaging method called [18F]CETO PET scan to better understand the cause of high blood pressure due to primary aldosteronism (PA). It may help guide treatment decisions without needing more invasive tests.
This study uses a new type of PET scan (called Gallium-68 Pentixafor PET-CT) to help doctors better identify the source of a hormone problem causing high blood pressure. The goal is to see if this scan leads to better surgical outcomes compared to standard methods.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.